In particular, genes such as MTND1P23, PLCH2, RNF223, PERM1, TAS1R3, and specific TMEM genes exhibit varied levels of expression across different tumour stages, thereby presenting a potential to discern early-stage ESCC from its later stages. This evidence concerns the gene PLCH2 and neoplasm.